Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

US Patent 10221243 · Granted Mar 5, 2019

Estimated economic value: $2,535,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for inhibition of the JAK pathway2023
Anticancer agents2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for can2023
Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for can2023
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Compositions and methods for inhibition of the JAK pathway2021
Anti-ROR1 antibodies2021
Anti-ROR1 antibodies2021
Methods of treating conditions with antibodies that bind colony stimulating fact2021